MHUA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
MHUA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Meihua International Medical Technologies Co's enterprise value is $6.35 Mil. Meihua International Medical Technologies Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was $12.56 Mil. Therefore, Meihua International Medical Technologies Co's EV-to-EBITDA for today is 0.51.
The historical rank and industry rank for Meihua International Medical Technologies Co's EV-to-EBITDA or its related term are showing as below:
During the past 5 years, the highest EV-to-EBITDA of Meihua International Medical Technologies Co was 70.28. The lowest was 0.14. And the median was 3.58.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-12-16), Meihua International Medical Technologies Co's stock price is $0.5009. Meihua International Medical Technologies Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was $0.370. Therefore, Meihua International Medical Technologies Co's PE Ratio (TTM) for today is 1.35.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
The historical data trend for Meihua International Medical Technologies Co's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Meihua International Medical Technologies Co Annual Data | |||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||
EV-to-EBITDA | - | - | - | 15.35 | 1.67 |
Meihua International Medical Technologies Co Semi-Annual Data | ||||||||||
Dec19 | Jun20 | Dec20 | Jun21 | Dec21 | Jun22 | Dec22 | Jun23 | Dec23 | Jun24 | |
EV-to-EBITDA | Get a 7-Day Free Trial | - | 15.35 | - | 1.67 | - |
For the Medical Instruments & Supplies subindustry, Meihua International Medical Technologies Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Meihua International Medical Technologies Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Meihua International Medical Technologies Co's EV-to-EBITDA falls into.
Meihua International Medical Technologies Co's EV-to-EBITDA for today is calculated as:
EV-to-EBITDA | = | Enterprise Value (Today) | / | EBITDA (TTM) |
= | 6.347 | / | 12.555 | |
= | 0.51 |
Meihua International Medical Technologies Co's current Enterprise Value is $6.35 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Meihua International Medical Technologies Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was $12.56 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Meihua International Medical Technologies Co (NAS:MHUA) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Meihua International Medical Technologies Co's PE Ratio (TTM) for today is calculated as:
PE Ratio (TTM) | = | Share Price (Today) | / | Earnings per Share (Diluted) (TTM) |
= | 0.5009 | / | 0.370 | |
= | 1.35 |
Meihua International Medical Technologies Co's share price for today is $0.5009.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Meihua International Medical Technologies Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was $0.370.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
Please read Which price ratio outperforms the enterprise multiple?
Thank you for viewing the detailed overview of Meihua International Medical Technologies Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
From GuruFocus
By PRNewswire • 07-31-2024
By PRNewswire PRNewswire • 06-09-2022
By GuruFocus News • 11-15-2024
By GuruFocus News • 12-02-2024
By PRNewswire • 12-28-2023
By PRNewswire PRNewswire • 05-01-2023
By PRNewswire • 06-11-2024
By PRNewswire PRNewswire • 05-20-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.